The story of Viagra presents a complex case for stakeholders in the medicinal sector. While initially a blockbuster success, creating billions, the intellectual property end and the subsequent flood of off-brand https://knockoff792020.ka-blogs.com/95292059/the-little-copyright-and-pharma-a-risky-play